These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23242174)

  • 1. Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.
    Ach T; Zeitler K; Schwarz-Furlan S; Baader K; Agaimy A; Rohrmeier C; Zenk J; Gosau M; Reichert TE; Brockhoff G; Ettl T
    Virchows Arch; 2013 Jan; 462(1):65-72. PubMed ID: 23242174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer.
    Ettl T; Baader K; Stiegler C; Müller M; Agaimy A; Zenk J; Kühnel T; Gosau M; Zeitler K; Schwarz S; Brockhoff G
    Br J Cancer; 2012 Feb; 106(4):719-26. PubMed ID: 22240798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of cervical lymph node metastasis in salivary gland cancer.
    Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H
    Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.
    Ach T; Schwarz-Furlan S; Ach S; Agaimy A; Gerken M; Rohrmeier C; Zenk J; Iro H; Brockhoff G; Ettl T
    J Oral Pathol Med; 2016 Aug; 45(7):500-9. PubMed ID: 26661925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.
    Freeman SS; Allen SW; Ganti R; Wu J; Ma J; Su X; Neale G; Dome JS; Daw NC; Khoury JD
    Cancer; 2008 Sep; 113(6):1453-61. PubMed ID: 18704985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
    Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
    Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
    Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
    Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
    Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.
    Suzuki S; Dobashi Y; Minato H; Tajiri R; Yoshizaki T; Ooi A
    Virchows Arch; 2012 Sep; 461(3):271-82. PubMed ID: 22828828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
    Go H; Jeon YK; Park HJ; Sung SW; Seo JW; Chung DH
    J Thorac Oncol; 2010 Mar; 5(3):305-13. PubMed ID: 20107422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients.
    Tanaka A; Sueoka-Aragane N; Nakamura T; Takeda Y; Mitsuoka M; Yamasaki F; Hayashi S; Sueoka E; Kimura S
    Lung Cancer; 2012 Jan; 75(1):89-94. PubMed ID: 21733594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
    Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
    Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
    J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.
    Kanteti R; Yala S; Ferguson MK; Salgia R
    J Environ Pathol Toxicol Oncol; 2009; 28(2):89-98. PubMed ID: 19817696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.
    Williams MD; Roberts DB; Kies MS; Mao L; Weber RS; El-Naggar AK
    Clin Cancer Res; 2010 Apr; 16(8):2266-74. PubMed ID: 20371674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ; Koh YW; Yoon SO
    Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.
    Lemound J; Schenk M; Keller G; Stucki-Koch A; Witting S; Kreipe H; Hussein K
    J Oral Pathol Med; 2016 Oct; 45(9):655-663. PubMed ID: 27037970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
    Lai GGY; Lim TH; Lim J; Liew PJR; Kwang XL; Nahar R; Aung ZW; Takano A; Lee YY; Lau DPX; Tan GS; Tan SH; Tan WL; Ang MK; Toh CK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Yuan J; Lim TKH; Lim AST; Hillmer AM; Lim WT; Iyer NG; Tam WL; Zhai W; Tan EH; Tan DSW
    J Clin Oncol; 2019 Apr; 37(11):876-884. PubMed ID: 30676858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.